Soleno Therapeutics (SLNO) Non-Current Deferred Tax Liability (2017 - 2023)

Soleno Therapeutics (SLNO) has 3 years of Non-Current Deferred Tax Liability data on file, last reported at $1.8 million in Q4 2023.

• On a quarterly basis, Non-Current Deferred Tax Liability changed N/A year-over-year to $1.8 million in Q4 2023; TTM through Dec 2023 was $1.8 million, a N/A change from a year earlier, with the FY2023 full-year figure at $1.8 million, changed N/A from the prior year.
• Non-Current Deferred Tax Liability for Q4 2023 stood at $1.8 million, up from $1.6 million in the prior quarter.
• Over the last five years, Non-Current Deferred Tax Liability for SLNO reached as high as $1.8 million in Q4 2023 and fell as low as $1.8 million in Q4 2023.